Table 1 The demographic and surgical information of FCD type I and II

From: Plasma extracellular vesicles-derived microRNAs provide potential biomarkers in distinguishing between focal cortical dysplasia type I and II

Characteristic

Overall (N = 439)

FCD Type I (N = 119)

FCD Type II (N = 320)

p-value

Gender

   

0.5

 Male

269 (61.28%)

76 (63.87%)

193 (60.31%)

 

 Female

170 (38.72%)

43 (36.13%)

127 (39.69%)

 

Seizure onset age (Days)

307 (96.50, 1009)

306 (97.00, 998)

315 (97.25, 1007)

0.7

Surgery age (Days)

1503 (850.00, 2492)

1589 (945.50, 2567)

1438 (800.25, 2486)

0.14

Frequency of seizures >10 times per day

156 (35.54%)

39 (32.77%)

117 (36.56%)

0.5

Surgery side

   

0.2

 Left

228 (51.94%)

68 (57.14%)

160 (50.00%)

 

 Right

211 (48.06%)

51 (42.86%)

160 (50.00%)

 

Lesion involving

 Frontal lobe

259 (59.00%)

53 (44.54%)

206 (64.38%)

<0.001

 Temporal lobe

180 (41.00%)

67 (56.30%)

113 (35.31%)

<0.001

 Parietal lobe

206 (46.92%)

53 (44.54%)

153 (47.81%)

0.5

 Occipital lobe

125 (28.47%)

48 (40.34%)

77 (24.06%)

<0.001

 Insula

141 (32.12%)

51 (42.86%)

90 (28.13%)

0.003

Lesion involving single lobe

213 (48.52%)

46 (38.66%)

167 (52.19%)

0.012

Lesion involving multiple lobes

226 (51.48%)

73 (61.34%)

153 (47.81%)

0.012

The number of lobes involved

   

0.011

 1

213 (48.52%)

46 (38.66%)

167 (52.19%)

 

 2

111 (25.28%)

33 (27.73%)

78 (24.38%)

 

 3

25 (5.69%)

9 (7.56%)

16 (5.00%)

 

 4

49 (11.16%)

22 (18.49%)

27 (8.44%)

 

 5

41 (9.34%)

9 (7.56%)

32 (10.00%)

 

Disconnection surgery

158 (35.99%)

65 (54.62%)

93 (29.06%)

<0.001

Only lesion-tailored resection

281 (64.01%)

54 (45.38%)

227 (70.94%)

<0.001

  1. *Median (IQR); n (%).
  2. FCD focal cortical dysplasia.